Fmoc-D-Lys-OH
CAS: 110990-08-4
Ref. 3D-KEA99008
1g | Discontinued | ||
2g | Discontinued | ||
5g | Discontinued | ||
10g | Discontinued | ||
25g | Discontinued | ||
250mg | Discontinued | ||
500mg | Discontinued | ||
2500mg | Discontinued |
Product Information
- (2R)-6-Amino-2-([[(9H-fluoren-9-yl)methoxy]carbonyl]amino)hexanoic acid
- (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-6-aminohexanoic acid
- <span class="text-smallcaps">D</span>-Lysine, N<sup>2</sup>-[(9H-fluoren-9-ylmethoxy)carbonyl]-
- D-Lys(Fmoc)
- D-lysine, N~2~-[(9H-fluoren-9-ylmethoxy)carbonyl]-
- Fmoc-<span class="text-smallcaps">D</span>-Lysine
- N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-D-lysine hydrochloride (1:1)
- N<sup>2</sup>-[(9H-Fluoren-9-ylmethoxy)carbonyl]-<span class="text-smallcaps">D</span>-lysine
- N~2~-[(9H-Fluoren-9-ylmethoxy)carbonyl]-D-lysine
- Fmoc-D-Lysine
- See more synonyms
- N2-[(9H-Fluoren-9-ylmethoxy)carbonyl]-D-lysine
- D-Lysine, N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-
Fmoc-D-Lys-OH is a synthetic drug that is structurally similar to theophylline. It binds to adenosine receptors and inhibits their activation by endogenous ligands, such as adenosine. Fmoc-D-Lys-OH has been used in the diagnosis of diseases in which there are changes in the congener or receptor subtype of adenosine receptors. This compound has also been used to study the reaction mechanism of theophylline and related drugs. The pharmacophore of this drug consists of a cyclohexene ring with a side chain that is either an amide or an ester group. The amide group is found in most compounds that bind to adenosine receptors, while the ester group is found in those that inhibit phosphodiesterase enzymes, such as theophylline.